Predictive Ability of the CHA 2 DS 2 ‐VA Score for No‐Reflow Phenomenon in ST‐Elevation Myocardial Infarction Patients Undergoing Primary PCI
Clinical Cardiology · 2026
DOI: 10.1002/clc.70439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Ying Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Liaocheng People's Hospital Affiliated to Shandong First Medical University, Liaocheng, Shandong, People's Republic of Chin…. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, No-Reflow Phenomenon, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial TCM Sci-Tech Program, Liaocheng People's Hospital Science Foundation.
Abstract (Originalsprache)
Background
No‐reflow phenomenon (NRP) frequently complicates ST‐elevation myocardial infarction (STEMI). This study evaluated the CHA 2 DS 2 ‐VA score (CV score) as a predictor of NRP in STEMI patients undergoing primary PCI.
Methods
A total of 725 STEMI patients were retrospectively enrolled and stratified by median of CV score (≤ 2 vs. > 2). The predictive ability of the CV score for NRP was assessed using logistic regression, receiver operating characteristic analysis, and DeLong tests.
Results
NRP incidence was higher in the high CV score group (15.2% vs. 8.7%, p = 0.007). The CV score predicted NRP overall (adjusted OR: 1.295, p = 0.002), but this effect was confined to females (AOR: 1.597, p = 0.002), with no significant association in males. Area under the curve value (AUC) of the CV score for predicting NRP was 0.613 in all patients (38.8% sensitivity and 79.1% specificity, p = 0.001) and 0.673 in females (78.1% sensitivity and 47.6% specificity, p = 0.002). A significant sex × CV score interaction ( p = 0.017) confirmed sex‐modified predictive value. DeLong tests combining the CV score with laboratory markers improved prediction in males but not females.
Conclusion
The CV score is a sex‐specific predictor of NRP in STEMI, with predictive value in females but not males. These findings support a tailored risk stratification approach: using the CV score alone for female patients, while integrating laboratory and procedural markers for male patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Liaocheng People's Hospital Affiliated to Shandong First Medical University, Liaocheng, Shandong, People's Republic of China.
- Department of Cardiology, Liaocheng Dongchangfu People's Hospital, Liaocheng People's Hospital Dongchangfu Campus, Liaocheng, Shandong, People's Republic of China.
- Liaocheng People's Hospital, Shandong University, Jinan, Shandong, People's Republic of China.
ORCID-Profile: Ying Sun, Hengchen Yao
Förderung
- Shandong Provincial TCM Sci-Tech Program
- Liaocheng People's Hospital Science Foundation
Zitieren
APA
Sun, Y., Ren, J., Wang, W., Wang, C., Liu, M., Liu, J., Qi, X., & Yao, H. (2026). Predictive Ability of the CHA 2 DS 2 ‐VA Score for No‐Reflow Phenomenon in ST‐Elevation Myocardial Infarction Patients Undergoing Primary PCI. Clinical Cardiology. https://doi.org/10.1002/clc.70439
Vancouver
Sun Y, Ren J, Wang W, Wang C, Liu M, Liu J, et al. Predictive Ability of the CHA 2 DS 2 ‐VA Score for No‐Reflow Phenomenon in ST‐Elevation Myocardial Infarction Patients Undergoing Primary PCI. Clinical Cardiology. 2026. doi:10.1002/clc.70439
BibTeX
@article{Sun2026,
author = {Sun, Ying and Ren, Jian and Wang, Wei and Wang, Chunsong and Liu, Min and Liu, Jiahui and Qi, Xuewen and Yao, Hengchen},
title = {Predictive Ability of the CHA 2 DS 2 ‐VA Score for No‐Reflow Phenomenon in ST‐Elevation Myocardial Infarction Patients Undergoing Primary PCI},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70439}
}
EUVIMED